News

By Rajesh T. Gandhi A randomized trial demonstrates that even those PWH at low-to-moderate risk for cardiovascular disease benefit from starting pitavastatin. Read the full article […]

By Paul Sax The biggest news this week at the 12th IAS Conference on HIV Science here in Brisbane, Australia, was the results of REPRIEVE, a large […]

By Larry Buhl A triumphant mood was evident at a session of the 12th International AIDS Society (IAS) Conference on HIV Science during which a panel […]

By Liz Highleyman REPRIEVE trial finds pitavastatin reduced the risk of heart attack, stroke and other major cardiovascular events by 35%. Read the full article here.

By Cara Murez Heart disease is a high risk for people with HIV, but a new study finds that taking statins significantly reduces the risk of […]

By Bianca Nogrady “I think the data are suggesting that it’s certainly in part due to the reduction in LDL — that is very important — […]

By Ed Susman The cholesterol-lowering agent pitavastatin (Livalo) as primary prevention reduced the risk of major adverse cardiovascular events (MACE) among people living with HIV, the […]

By Deborah Balthazar A statin a day reduces the risk of heart disease in younger people living with HIV, according to a new study published Sunday in the […]

By Liz Highleyman A widely used statin medication reduced the risk of heart attacks, strokes and other cardiovascular events when given to people with HIV who […]